Neurocrine Biosciences: Q3 Earnings Insights

Neurocrine Biosciences NBIX reported its Q3 earnings results on Monday, November 1, 2021 at 04:01 PM.

Here's what investors need to know about the announcement.

Neurocrine Biosciences reported in-line EPS of $0.64 versus an estimate of $0.6, which did not surprise analysts.

Revenue was up $37,500,000 from the same period last year.

Last quarter the company beat on EPS by $0.14, which was followed by a 4.61% drop in the share price the next day.

Here's a look at Neurocrine Biosciences's past performance:

Quarter	Q2 2021	Q1 2021	Q4 2020	Q3 2020
EPS Estimate	0.49	0.51	0.54	0.22
EPS Actual	0.63	0.49	0.91	0.97
Revenue Estimate	274.38M	250.63M	262.40M	283.04M
Revenue Actual	288.90M	236.60M	247.90M	258.50M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

Earnings Calendar